All Relations between cud and cannabis

Publication Sentence Publish Date Extraction Date Species
Derek B Kosty, John R Seeley, Richard F Farmer, Joseph J Stevens, Peter M Lewinsoh. Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes. Addiction (Abingdon, England). vol 112. issue 2. 2018-02-22. PMID:27515021. to estimate cannabis use disorder (cud) trajectory classes from ages 14 to 30 years and compare classes on clinical characteristics, risk factors and psychosocial outcomes. 2018-02-22 2023-08-13 Not clear
Jose M Trigo, Alexandra Soliman, Lena C Quilty, Benedikt Fischer, Jürgen Rehm, Peter Selby, Allan J Barnes, Marilyn A Huestis, Tony P George, David L Streiner, Gregory Staios, Bernard Le Fol. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. PloS one. vol 13. issue 1. 2018-02-21. PMID:29385147. the current lack of pharmacological treatments for cannabis use disorder (cud) warrants novel approaches and further investigation of promising pharmacotherapy. 2018-02-21 2023-08-13 human
Julia D Buckner, Michael J Zvolensky, Anthony H Ecker, Emily R Jeffries, Austin W Lemke, Kimberlye E Dean, Michael S Businelle, Matthew W Gallaghe. Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors. Addictive behaviors. vol 70. 2018-02-14. PMID:28214433. cannabis use disorder (cud) co-occurs with anxiety disorders at high rates. 2018-02-14 2023-08-13 Not clear
Julia D Buckner, Michael J Zvolensky, Anthony H Ecker, Emily R Jeffries, Austin W Lemke, Kimberlye E Dean, Michael S Businelle, Matthew W Gallaghe. Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors. Addictive behaviors. vol 70. 2018-02-14. PMID:28214433. the present study tested whether fsb use explained the relation of anxiety symptom severity with cannabis quantity and related problems among 77 adults with cud and comorbid anxiety disorders seeking outpatient cud treatment. 2018-02-14 2023-08-13 Not clear
Julia D Buckner, Michael J Zvolensky, Anthony H Ecker, Emily R Jeffries, Austin W Lemke, Kimberlye E Dean, Michael S Businelle, Matthew W Gallaghe. Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors. Addictive behaviors. vol 70. 2018-02-14. PMID:28214433. these novel findings suggest that more frequent use of fsbs may play an important role in cannabis problem severity among individuals with cud and anxiety disorders. 2018-02-14 2023-08-13 Not clear
Yifrah Kaminer, Christine McCauley Ohannessian, Rebecca H Burk. Adolescents with cannabis use disorders: Adaptive treatment for poor responders. Addictive behaviors. vol 70. 2018-02-14. PMID:28232290. treatment response as measured by both retention and abstinence attainment rates for adolescents with cannabis use disorders (cud) has been unsatisfactory. 2018-02-14 2023-08-13 Not clear
Jung Yeon Lee, Judith S Brook, Mario De La Rosa, Youngjin Kim, David W Broo. The association between alcohol use trajectories from adolescence to adulthood and cannabis use disorder in adulthood: a 22-year longitudinal study. The American journal of drug and alcohol abuse. vol 43. issue 6. 2018-02-05. PMID:28635349. due to the increasing prevalence of cannabis use disorder (cud), the impact of cannabis use on public health may be significant. 2018-02-05 2023-08-13 Not clear
Marise Wj Machielsen, Dick J Veltman, Wim van den Brink, Lieuwe de Haa. The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study. Journal of psychopharmacology (Oxford, England). vol 28. issue 7. 2018-01-16. PMID:24646809. clozapine-treated cud patients showed a larger reduction in craving and in activation of the insula during the cannabis word stroop, while risperidone-treated patients showed a larger decrease in activation of the right anterior cingulate cortex during the classical stroop. 2018-01-16 2023-08-12 Not clear
William E Copeland, Sherika Hill, E Jane Costello, Lilly Shanaha. Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians. Journal of the American Academy of Child and Adolescent Psychiatry. vol 56. issue 2. 2017-12-27. PMID:28117058. recent changes in dsm criteria require new documentation of the prevalence and developmental sequences of cannabis use disorder (cud). 2017-12-27 2023-08-13 Not clear
Kristen Sonon, Gale A Richardson, Jack Cornelius, Kevin H Kim, Nancy L Da. Developmental pathways from prenatal marijuana exposure to Cannabis Use Disorder in young adulthood. Neurotoxicology and teratology. vol 58. 2017-12-22. PMID:27208888. there are no reports of the association between pme and cannabis use disorder (cud) at 22years, the age when use of marijuana and cud peak. 2017-12-22 2023-08-13 Not clear
Bryan Hartzler, Beatriz H Carlini, Howard Newville, Heidi M Crane, Joseph J Eron, Elvin H Geng, W Christopher Mathews, Kenneth H Mayer, Richard D Moore, Michael J Mugavero, Sonia Napravnik, Benigno Rodriguez, Dennis M Donova. Identifying HIV care enrollees at-risk for cannabis use disorder. AIDS care. vol 29. issue 7. 2017-12-22. PMID:28006972. increased scientific attention given to cannabis in the united states has particular relevance for its domestic hiv care population, given that evidence exists for both cannabis as a therapeutic agent and cannabis use disorder (cud) as a barrier to antiretroviral medication adherence. 2017-12-22 2023-08-13 Not clear
Bryan Hartzler, Beatriz H Carlini, Howard Newville, Heidi M Crane, Joseph J Eron, Elvin H Geng, W Christopher Mathews, Kenneth H Mayer, Richard D Moore, Michael J Mugavero, Sonia Napravnik, Benigno Rodriguez, Dennis M Donova. Identifying HIV care enrollees at-risk for cannabis use disorder. AIDS care. vol 29. issue 7. 2017-12-22. PMID:28006972. based on a patient-report instrument with validated diagnostic threshold for cud, the prevalence of recent cannabis use and corresponding conditional probabilities for cud were calculated for the aggregate sample and demographic subgroups. 2017-12-22 2023-08-13 Not clear
Katherine T Foster, Ningfei Li, Erin A McClure, Susan C Sonne, Kevin M Gra. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. Journal of substance abuse treatment. vol 66. 2017-12-07. PMID:27211992. while internalizing distress and suicide risk have been linked with cannabis use problems [dsm-5 cannabis use disorder (cud); dsm-iv cannabis abuse and dependence] it remains unclear how this association varies over the course of development in treatment-seeking men and women. 2017-12-07 2023-08-13 Not clear
Evan S Herrmann, Ziva D Cooper, Gillinder Bedi, Divya Ramesh, Stephanie C Reed, Sandra D Comer, Richard W Foltin, Margaret Hane. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. Psychopharmacology. vol 233. issue 13. 2017-12-04. PMID:27085870. each year, over 300,000 individuals in the usa enter treatment for cannabis use disorder (cud). 2017-12-04 2023-08-13 Not clear
David A Gorelic. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review. Current pharmaceutical design. vol 22. issue 42. 2017-12-04. PMID:27549375. cannabis is the most widely used illicit psychoactive substance world-wide, yet no medication is approved for the treatment of intoxication, withdrawal, or cannabis use disorder (cud). 2017-12-04 2023-08-13 Not clear
Daniel Feingold, Jürgen Rehm, Shaul Lev-Ra. Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. Psychiatry research. vol 251. 2017-11-30. PMID:28214781. cannabis users without a cannabis use disorder (cuds) and individuals with a cud were compared to nonusers using linear and logistic regression analyses controlling for sociodemographics, psychiatric disorders and substance use disorders at baseline. 2017-11-30 2023-08-13 Not clear
Matthew Goldenberg, Waguih William IsHak, Itai Danovitc. Quality of life and recreational cannabis use. The American journal on addictions. vol 26. issue 1. 2017-11-27. PMID:28000973. we hypothesized that qol would be unchanged or increased among recreational cannabis users, who did not meet criteria for a cannabis use disorder (cud) and that qol would be lower among those who met criteria for a cud. 2017-11-27 2023-08-13 Not clear
Angelique G Brellenthin, Kelli F Kolty. Exercise as an adjunctive treatment for cannabis use disorder. The American journal of drug and alcohol abuse. vol 42. issue 5. 2017-11-06. PMID:27314543. despite cannabis being the most widely used illicit substance in the united states, individuals diagnosed with cannabis use disorder (cud) have few well-researched, affordable treatment options available to them. 2017-11-06 2023-08-13 Not clear
Li-Tzy Wu, He Zhu, Marvin S Swart. Trends in cannabis use disorders among racial/ethnic population groups in the United States. Drug and alcohol dependence. vol 165. 2017-10-11. PMID:27317045. given increased concerns of cannabis use (cu) and its associations with health conditions, we examined national trends in cannabis use disorder (cud) among adults aged ≥18 by race/ethnicity. 2017-10-11 2023-08-13 Not clear
Nathan A Kimbrel, Amie R Newins, Eric A Dedert, Elizabeth E Van Voorhees, Eric B Elbogen, Jennifer C Naylor, H Ryan Wagner, Mira Brancu, Jean C Beckham, Patrick S Calhou. Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans. Journal of psychiatric research. vol 89. 2017-09-19. PMID:28129565. the objective of the present research was to examine the association between lifetime cannabis use disorder (cud), current suicidal ideation, and lifetime history of suicide attempts in a large and diverse sample of iraq/afghanistan-era veterans (n = 3233) using a battery of well-validated instruments. 2017-09-19 2023-08-13 Not clear